Impact BioMedical Inc.
IBO
$0.8569
-$0.0731-7.86%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 114.63% | -22.81% | |||
| Depreciation & Amortization | 0.72% | -0.36% | |||
| Other Operating Expenses | 275.00% | 71.43% | |||
| Total Operating Expenses | 80.03% | -18.81% | |||
| Operating Income | -80.03% | 18.81% | |||
| Income Before Tax | 579.75% | 11.42% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 579.75% | 11.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 220.00% | -113.89% | |||
| Net Income | 577.73% | 7.59% | |||
| EBIT | -80.03% | 18.81% | |||
| EBITDA | -80.00% | 18.73% | |||
| EPS Basic | 515.30% | 7.59% | |||
| Normalized Basic EPS | 513.80% | 5.10% | |||
| EPS Diluted | 166.67% | 10.00% | |||
| Normalized Diluted EPS | 166.13% | 5.10% | |||
| Average Basic Shares Outstanding | 15.07% | -0.02% | |||
| Average Diluted Shares Outstanding | 620.17% | -0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
